SLAMF7, also known as novel Ly9, CD319, CS1, 19A24 or CRACC, is a homophilic cell surface receptor. It is a member of the SLAM (signaling lymphocytic activation molecule) family of receptors expressed on natural killer (NK) cells, T cells and stimulated B cells. SLAMF7 contains immunoreceptor tyrosine-based switch motifs in its cytoplasmic domain but, unlike other SLAM receptors, it does not recruit SAP (SLAM-associated protein). In humans, SLAMF7 activates NK cells through an EAT-2-mediated pathway that is SAP-independent. SLAMF7 recruits and associates with EAT2, a protein closely related to SAP. EAT2 induces phosphorylation of SLAMF7 which then, upon ligand binding, activates downstream cytotoxicity effectors PLC and PI 3K.
Clone
MD381
Isotype
IgG1k
Host species
Mouse
Species Reactivity
Human
Cellular Localization
Membrane
Positive Control
Tonsil, spleen
Applications
IHC
Intended Use
Research Use Only
![SLAMF7 (CD319 CS1) [MD381]](https://medaysis.com/wp-content/uploads/2025/08/SLAMF7-MD381-MC0089_human-spleen-e1756426755791.jpg)